ArriVent BioPharmaAVBP

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1

$644.4M

Market Cap • 24/05/2024

2021

(há 3 anos)
Fundação

2024

IPO

NASDAQ

Listagem
Flag of US

Philadelphia

Sede • Pennsylvania

Valuation

Valuation Indicators

Retorno Histórico

AVBPSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

-4%

1 dia

21/05/2024

-4%

1 semana

17/05/2024

26%

1 mês

24/04/2024

10 anos

Histórico